Trial Profile
A Multicenter, Randomized, Investigator-Blinded, Phase 2, Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 May 2013
Price :
$35
*
At a glance
- Drugs Metronidazole (Primary)
- Indications Bacterial infections; Bacterial vaginosis
- Focus Therapeutic Use
- 08 May 2013 Results presented at the 61st Annual Clinical Meeting of the American College of Obstetricians and Gynecologists.
- 14 May 2010 Actual patient number (255) added as reported by ClinicalTrials.gov.
- 14 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.